Comments
Supreme Court won't review J&J-Abbott patent case
22.02.2012. | WASHINGTON (Reuters) - The Supreme Court on Tuesday declined to review a ruling that Abbott Laboratories' Humira arthritis drug did not infringe a patent owned by a Johnson & Johnson subsidiary and that threw out a $1.67 billion damage award against Abbott....
